You are correct though that inflammation is a big player in CVD, and brand new guidelines agree with you. They now say that CRP and other markers should be taken into consideration and targeted for treatment in the same manner as cholesterol: https://www.jacc.org/doi/epdf/10.1016/j.jacc.2025.08.047
The problem is, lowering inflammation is very tricky because itβs so hard to define. CRP, ESR, various cytokines etc are only indicative, and all of them are non-specific. You can also be terribly unhealthy and those markers are totally normal.
I think D-Dimer is another under-rated inflammation marker, as is ferritin. Worth looking at those too IMO.
I take statins to lower inflammation as much as apob.
I have a cor one i havent used much in a while. Its hard to keep doing experiments without an algorithm.